Latitude Pharmaceuticals (United States)

Latitude Pharmaceuticals (United States)

Open Access statistics for Latitude Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023.

Open Access statistics for Latitude Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

75%


Total
Publications

60


Total Open
Publications

45


Total
Citations

2.6K


Open Access
Percentage

75%


Total
Publications

60


Total Open
Publications

45


Total
Citations

2.6K

Website

download

Breakdown

50% 17% 8% 25%

Publisher Open

50%

Both

17%

Other Platform Open

8%

Closed

25%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

8

Hybrid 28%

11

No Guarantees 52%

21

Other Platform Open

Other Internet 60%

9

Institution 53%

8

Preprint 13%

2

Domain 7%

1

Public 7%

1

Other Platform Locations

Name

Platform Type

Publications

University of Birmingham - University of Birmingham Research Portal
Institution
6
Radboud University - Radboud Repository
Institution
5
University of Bath - University of Bath Research Portal
Institution
4
Spanish National Research Council (CSIC) - DIGITAL.CSIC
Institution
4
Institute of Nuclear Sciences "Vinča" - VinaR - Repository of the Vinča Nuclear Institute
Institution
4
Unknown Repository
Other Internet
3
University of Malta - OAR@UM
Institution
3
University of Jyväskylä - Jyväskylä University Digital Archive
Institution
3
University of Copenhagen - Research at the University of Copenhagen
Institution
3
unige.it OAI-PMH Repository
Institution
3
1 / 7

Data updated 8 December 2024

Share

Share

Share